Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-03, Stock:LLY, The news for the past five days is as follows:
2019-06-26: NEWS1: Wednesday Sector Laggards: Utilities, Healthcare.NEWS2: Wednesday Sector Laggards: Utilities, Healthcare.NEWS3: Lilly's Heart Drug Snags Fast Track Designation; Type 2 Diabetes Drug Found Effective At Higher Doses.NEWS4: The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart.NEWS5: Lilly's AWARD-11 trial studying higher investigational doses of Trulicity® (dulaglutide) demonstrated superiority in A1C reduction in people with type 2 diabetes.NEWS6: U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure.
2019-06-27: NEWS1: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS2: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS3: 3 Big Stock Charts for Thursday: H & R Block, Boeing and Eli Lilly.NEWS4: 3 Big Stock Charts for Thursday: H & R Block, Boeing and Eli Lilly.NEWS5: XLV, AMGN, LLY, SYK: ETF Outflow Alert.NEWS6: XLV, AMGN, LLY, SYK: ETF Outflow Alert.NEWS7: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.
2019-06-28: NEWS1: How Eli Lilly’s EPS and Expenses Are Trending.NEWS2: How Is Eli Lilly’s Revenue Trending in 2019?.NEWS3: What Analysts Recommend for LLY and AMGN.NEWS4: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS5: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS6: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.
2019-07-01: NEWS1: Pain and Immunology: Eli Lilly’s Key Growth Areas.NEWS2: Market Morning: OPEC Cuts, Trump & Xi Ceasefire, Apple Goes to China, Deutsche Bank Hiring.
2019-07-02: NEWS1: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS2: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS3: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS4: 13 Blue-Chip Stocks With Risks You Need to Watch.NEWS5: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS6: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS7: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.

Answer: Rise